Zymeworks ZYME
NASDAQ ZYME
$27.00 -0.20 (-0.74%)
As of: Sep 30, 2026 · 3:19 PM EDT

Zymeworks (ZYME) EBIT Margin (2021 - 2026)

Updated

Zymeworks' EBIT Margin came in at -918.95% for Q2 2026, down 917.57 percentage points from -1.38% a year earlier but up 1037.77 percentage points from the prior quarter.

Analysis

Zymeworks (ZYME) EBIT Margin (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Zymeworks reported EBIT Margin of -418.99%, down 351.68 percentage points year-over-year; for FY2025, it came in at -87.34%, up 92.35 percentage points from FY2024.

  • EBIT Margin carries a five-year change of +393.95 percentage points (FY2020 to FY2025).
  • Going back by year, EBIT Margin was -179.69% in FY2024 (+1.93 pp), -181.62% in FY2023 (-213.26 pp), 31.64% in FY2022 (+839.86 pp) and -808.22% in FY2021 (-326.93 pp).
  • The five-year range for quarterly EBIT Margin is -3793.63% (Q1 2022) to 79.35% (Q4 2022).
  • Year-over-year, EBIT Margin has declined for three consecutive quarters, with an average year-over-year change of -471.48 percentage points over the last eight quarters.
  • The fastest year-over-year change in EBIT Margin over five years came in Q1 2023 (a gain of 3716.95 percentage points), and the weakest in Q1 2026 (a drop of 1862.25 percentage points).
  • Business Quant data shows ZYME's EBIT Margin at -1956.73% (Q1 2026), -1755.55% (Q4 2025) and -80.07% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Zymeworks 1.94 Bn 826.25 Mn - -918.95%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -918.95%
Mar 31, 2026 -1,956.73%
Dec 31, 2025 -1,755.55%
Sep 30, 2025 -80.07%
Jun 30, 2025 -1.38%
Mar 31, 2025 -94.48%
Dec 31, 2024 -71.60%
Sep 30, 2024 -213.78%
Jun 30, 2024 -222.87%
Mar 31, 2024 -376.89%
Dec 31, 2023 -138.37%
Sep 30, 2023 -201.36%
Jun 30, 2023 -772.84%
Mar 31, 2023 -76.68%
Dec 31, 2022 79.35%
Sep 30, 2022 -1,914.03%
Jun 30, 2022 -1,209.54%
Mar 31, 2022 -3,793.63%
Dec 31, 2021 -205.58%
Sep 30, 2021 -1,387.12%
API Access

Zymeworks EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ZYME&period=max&api_key=YOUR_API_KEY